Asia Pacific Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; End User; and Country

According to a new market research study of ‘Asia Pacific Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Analysis by product, and end-user’ the Asia Pacific kidney disease market is expected to reach US$ 37.204.4 million in 2027 from US$ 21,930.1 in 2019. The market is estimated to grow with a CAGR of 6.9% from 2020-2027. The report provides trends prevailing in the Asia Pacific kidney disease market and the factors driving market along with those that act as hindrances.

Based on the product, the Asia Pacific the kidney disease market, is segmented into diagnosis and treatment. The diagnosis segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. The Chronic kidney disease (CKD) can be diagnosed with blood and urine tests. Diagnosis of kidney disease is made with various tests such as blood tests, urine tests, imaging tests, and others. The tests must be performed in conditions such as diabetes, high blood pressure, heart disease, and a family history of kidney failure. Early kidney disease usually doesn’t have any symptoms. Testing is the only way to know how well kidneys are working.

The growth of this market is estimated to grow owing to key driving factors such as increasing incidences of end-stage diseases and high development in government expenditure in the healthcare industry. However, the market is expected experiencing slow growth during the forecast period owing to a high cost of dialysis treatment in Asia Pacific region.

Abbott, Teva Pharmaceutical Industries Ltd, and F. Hoffmann-La Roche Ltd are among the leading companies operating in the Asia Pacific kidney disease market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific kidney disease market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific kidney disease market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

1. Introduction

1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Kidney Disease Market - by Product
1.3.2 Kidney Disease Market - by End User
1.3.3 Asia Pacific Kidney Disease - by Country

2. Asia Pacific Kidney Disease - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Kidney Disease - Market Landscape

4.1 Overview
4.2 PEST Analysis
4.2.1 Kidney Disease Market- Asia Pacific PEST Analysis
4.3 Expert Opinion

5. Asia Pacific Kidney Disease - Key Market Dynamics

5.1 Market Drivers
5.1.1 Increasing Incidences of ESRD(End-Stage Renal Disease)
5.1.2 High Development in Government Expenditure in the Healthcare Industry
5.2 Market Restraints
5.2.1 High Cost of Dialysis Treatment in Asia Pacific Region
5.3 Market Opportunities
5.3.1 Increased Research & Development across the Region
5.4 Future Trends
5.4.1 Increased Number of Market Players
5.5 Impact Analysis

6. Kidney Disease Market - Asia Pacific Analysis

6.1 Asia Pacific Kidney Disease Revenue Forecasts and Analysis

7. Asia Pacific Kidney Disease Analysis and Forecasts to 2027 - ByProduct

7.1 Overview
7.2 Kidney Disease Market Revenue Share, by Product (2019 and 2027)
7.3 Diagnosis
7.3.1 Overview
7.3.2 Diagnosis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.3.3 Blood Tests
7.3.3.1 Overview
7.3.3.2 Blood Tests: Kidney Disease Market - Revenue and Forecast to 2027(US$ Million)
7.3.4 Urine Tests
7.3.4.1 Overview
7.3.4.2 Urine Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.3.5 Imaging Tests
7.3.5.1 Overview
7.3.5.2 Imaging Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.3.6 Others
7.3.6.1 Overview
7.3.6.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Treatment
7.4.1 Overview
7.4.2 Treatment: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3 Drug Class
7.4.3.1 Overview
7.4.3.2 Drug Class: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.1 ACE Inhibitors
7.4.3.2.1.1 Overview
7.4.3.2.1.2 ACE Inhibitors: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.2 Angiotensin-II Receptor Blockers
7.4.3.2.2.1 Overview
7.4.3.2.2.2 Angiotensin-II Receptor Blockers: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.3 Diuretics
7.4.3.2.3.1 Overview
7.4.3.2.3.2 Diuretics: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.4 Others
7.4.3.2.4.1 Overview
7.4.3.2.4.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.4 Dialysis
7.4.4.1 Overview
7.4.4.2 Dialysis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.5 Others
7.4.5.1 Overview
7.4.5.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)

8. Asia Pacific Kidney Disease Analysis - by End-User

8.1 Overview
8.2 Kidney Disease Market Revenue Share, by End User (2019 and 2027)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)

9. Kidney Disease Market Revenue and Forecasts to 2027 - Geographical Analysis

9.1 Asia Pacific: Kidney Disease Market
9.1.1 Overview
9.1.2 Asia Pacific: Kidney Disease Market, - Revenue and Forecast to 2027 (USD Million)
9.1.2.1 Canada: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.2.1.1 Asia Pacific: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.2.1.2 Asia Pacific: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.2.1.2.1 Asia Pacific: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.2.2 Asia Pacific: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.3 Asia Pacific: Kidney Disease Market, by Country, 2019 & 2027 (%)
9.1.4 Japan: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.4.1 Japan: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.4.2 Japan: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.1.4.2.1 Japan: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.4.2.2 Japan: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.4.2.2.1 Japan: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.4.3 Japan: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.5 China: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.1 China: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.5.2 China: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.1.5.2.1 China: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.5.2.2 China: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.5.2.2.1 China: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.5.3 China: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.6 India: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 India: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 India: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.1.6.2.1 India: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2 India: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2.1 India: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.6.3 India: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.7 South Korea: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 South Korea: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 South Korea: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.1 South Korea: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2 South Korea: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2.1 South Korea: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.7.3 South Korea: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.8 Australia: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Australia: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Australia: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.1 Australia: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2 Australia: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2.1 Australia: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Australia: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)

10. Impact Of COVID-19 Pandemic on Asia Pacific Kidney disease

10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

11. COMPANY PROFILES

11.1 Abbott
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Teva Pharmaceutical Industries Ltd
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 GlaxoSmithKline plc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments

12. Appendix

12.1 About the Publisher
12.2 Glossary of terms

List of Tables

Table 1. Canada: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 3. Asia Pacific: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 4. Asia Pacific: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 5. Asia Pacific: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 6. Japan: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 7. Japan: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 8. Japan: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 9. Japan: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 10. Japan: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 11. China: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 12. China: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 13. China: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 14. China: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 15. China: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 16. India: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 17. India: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 18. India: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 19. India: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 20. India: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 21. South Korea: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 22. South Korea: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 23. South Korea: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 24. South Korea: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 25. South Korea: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 26. Australia: Kidney Disease Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 27. Australia: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
Table 28. Australia: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
Table 29. Australia: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 30. Australia: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 31. Glossary of Terms,Kidney disease

List of Figures

Figure 1. Kidney Disease Segmentation
Figure 2. Asia PacificKidney Disease Overview
Figure 3. Diagnosis Segment Held Largest Share of Product inKidney Disease Market
Figure 4. China is Expected to show Remarkable Growth during the Forecast Period
Figure 5. Kidney Disease Market - Asia Pacific PEST Analysis
Figure 6. Kidney Disease Market Impact Analysis of Driver and Restraints
Figure 7. Asia PacificKidney Disease - Revenue Forecasts and Analysis-2019-2027
Figure 8. Kidney Disease Market Revenue Share, by Product (2019 and 2027)
Figure 9. Diagnosis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 10. Blood Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 11. Urine Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Imaging Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Treatment: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Drug Class: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. ACE Inhibitors: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Angiotensin-II Receptor Blockers: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Diuretics: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Dialysis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Kidney Disease Market Revenue Share, by End User (2019 and 2027)
Figure 23. Hospitals: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Diagnostic Laboratories: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Asia Pacific: Kidney Disease Market, by Key Country - Revenue (2019) (USD Million)
Figure 27. Asia Pacific: Kidney Disease Market, Revenue and Forecast to 2027 (USD Million)
Figure 28. Asia Pacific: Kidney Disease Market, by Country, 2019 & 2027 (%)
Figure 29. Japan: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
Figure 30. China: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
Figure 31. India: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
Figure 32. South Korea: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
Figure 33. Australia: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
Figure 34. Impact of COVID-19 Pandemic in Asia Pacificon Country Markets

Companies Mentioned

Abbott
F. Hoffmann-La Roche Ltd
AbbVieInc
Pfizer Inc
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline plc
Sysmex Corporation
Siemens AG

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2052EUR$2,100USD£1,713GBP €2931EUR$3,000USD£2,447GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€2736EUR$2,800USD£2,284GBP €3908EUR$4,000USD£3,263GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3420EUR$3,500USD£2,855GBP €4885EUR$5,000USD£4,078GBP

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Polycystic Kidney Disease Drugs Market by Type, Treatment, Diagnosis, Distribution Channels, End-User - Global Forecast 2025-2030

Chronic Kidney Disease Market by Type, Indication, End-User - Global Forecast 2025-2030

Polycystic Kidney Disease Market

Chronic Kidney Disease Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications, Type of Molecule, Type of Biologics, Route of Administration, Type of Therapy, Key Geographical Regions, Leading Drug Developers and Sales Forecast